Nesar Shagufta, Shoaib Muhammad Harris, Rafiq Kiran, Rahim Najia, Muhammad Iyad Naeem, Iffat Wajiha
Faculty of Pharmacy, Hamdard University, Karachi, Pakistan.
Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi, Pakistan.
Pak J Pharm Sci. 2018 Jan;31(1):113-117.
Prescriptions comprising multi-drug therapy mostly illustrate the prescribing error. The phenomenon of error is bonded with human inaccuracy. The erroneous practice is observed in under developed countries like Pakistan, Bangladesh and also in developed ones. Consequently drug-drug interaction is one of the most common error associated with potentially serious adverse response even death. Accordingly the present study was conducted to assess the prevalence of prescribing errors and drug-drug interactions in out-patients receiving angiotensin receptor blockers. The study was done with population size one hundred fifty prescriptions obtained from different out-patient settings in Karachi. The prescriptions were screened for prescribing errors and risk factors for drug-drug interactions. Drug-drug interactions were recognized by Micromedex.2.0.Drug-Reax®database. The most common type of error was omission error. These errors were patient's age, weight and diagnosis found in 51.3%, 97.3% and 74% of prescriptions, respectively. The prevalence of drug-drug interaction was 38%. A total of 746 drugs were prescribed with an average of 5 drugs per prescription and 450 medication errors were detected. Majority of the interaction were moderate (19.33%), others were minor (14%) and major (6%) in severity. Patients who prescribed many drugs (more than 5 drugs in a while) had a higher risk of developing drug-drug interactions (OR=4.76; 95% CI=2.30-9.64; p=0.0001*).The study data reports the occurrence of prescribing errors in Karachi and also necessitate the need of clinical pharmacist's services in health care system. The step will help to minimize the risk factors by having the drug prescriptions reviewed by the pharmacists.
包含多药疗法的处方大多存在用药错误。错误现象与人为失误相关。在巴基斯坦、孟加拉国等发展中国家以及发达国家都观察到了这种错误行为。因此,药物相互作用是最常见的错误之一,可能会导致严重的不良反应甚至死亡。据此,本研究旨在评估接受血管紧张素受体阻滞剂治疗的门诊患者中用药错误和药物相互作用的发生率。该研究以从卡拉奇不同门诊机构获取的150份处方为研究对象。对这些处方进行用药错误和药物相互作用风险因素筛查。通过Micromedex.2.0.Drug-Reax®数据库识别药物相互作用。最常见的错误类型是遗漏错误。这些错误分别在51.3%、97.3%和74%的处方中出现于患者年龄、体重和诊断方面。药物相互作用的发生率为38%。总共开出了746种药物,平均每张处方5种药物,共检测到450例用药错误。大多数相互作用为中度(19.33%),其他为轻度(14%)和重度(6%)。同时开具多种药物(一次超过5种药物)的患者发生药物相互作用的风险更高(比值比=4.76;95%置信区间=2.30 - 9.64;p=0.0001*)。研究数据报告了卡拉奇用药错误的发生情况,也表明医疗保健系统需要临床药师服务。这一步骤将有助于通过让药师审查药物处方来降低风险因素。